Positron Emission Tomography Scanners Market to Reach USD 1028.40 Million by 2032, Driven by Rising Cancer Diagnostics Demand
The global Positron Emission Tomography Scanners Market was valued at USD 650.12 million in 2024 and is projected to grow at a CAGR of 5.9% from 2025 to 2032, reaching nearly USD 1028.40 million by 2032. The market growth is being fueled by the increasing prevalence of cancer, neurological disorders, and cardiovascular diseases, along with advancements in hybrid imaging technologies such as PET/CT and PET/MRI systems.
Rising Burden of Chronic Diseases Accelerates PET Scanner Adoption
Positron Emission Tomography (PET) scanners have become a critical diagnostic tool in modern healthcare due to their ability to provide detailed insights into the metabolic and functional activities of tissues and organs. PET imaging enables early disease detection, often before abnormalities become visible through conventional imaging techniques.
The growing incidence of cancer worldwide remains one of the strongest drivers for the PET scanners market. PET scans are widely used in oncology for tumor detection, cancer staging, therapy monitoring, and recurrence evaluation. Increasing awareness regarding early diagnosis and precision medicine is significantly contributing to market expansion.
In addition to oncology, PET technology is gaining traction in neurology and cardiology applications. PET imaging plays an important role in identifying neurological conditions such as Alzheimer’s disease, epilepsy, and Parkinson’s disease, while also supporting cardiovascular assessments through myocardial viability studies.
To know about the Research Methodology :-https://www.maximizemarketresearch.com/request-sample/104613/
Technological Advancements Strengthen Market Growth
Continuous innovations in PET imaging technology are reshaping the diagnostic imaging landscape. The integration of PET with computed tomography (CT) and magnetic resonance imaging (MRI) has improved image accuracy, enabling clinicians to obtain comprehensive anatomical and metabolic information simultaneously.
The launch of advanced total-body PET scanners, such as the EXPLORER PET/CT system, has further enhanced imaging quality while reducing scan time and radiotracer dosage requirements. These next-generation systems are improving patient comfort and diagnostic efficiency, particularly in oncology applications.
Growing investments in radiopharmaceutical research and development are also creating new opportunities for the market. Increased use of tracers such as 18F-fluorodeoxyglucose (FDG) is supporting broader clinical applications of PET imaging across multiple therapeutic areas.
Hospitals Segment Dominates the End-User Landscape
Based on end users, the hospitals segment held the largest share of the global PET scanners market in 2024 and is expected to maintain its dominance during the forecast period. Hospitals continue to invest heavily in advanced imaging infrastructure to support complex disease diagnosis and treatment planning.
The high patient inflow in hospitals, combined with their ability to adopt cutting-edge imaging technologies, is driving demand for PET scanners. Hospitals are also major centers for clinical trials and research studies, further increasing the adoption of precision imaging solutions.
Diagnostic imaging centers are also witnessing steady growth due to rising demand for specialized imaging services and expanding outpatient diagnostic procedures.
North America Leads the Global Market
Regionally, North America dominates the global PET scanners market owing to the strong presence of advanced healthcare infrastructure, high healthcare spending, and increasing awareness regarding early disease diagnosis.
The United States remains the largest contributor to regional growth due to growing cancer prevalence, favorable reimbursement policies, and rapid adoption of technologically advanced imaging systems.
Meanwhile, the Asia Pacific region is expected to witness significant growth during the forecast period, supported by expanding healthcare investments, rising geriatric populations, and increasing access to advanced diagnostic technologies in countries such as China, India, and Japan.
To know about the Research Methodology :-https://www.maximizemarketresearch.com/request-sample/104613/
Market Challenges
Despite strong growth prospects, the PET scanners market faces several challenges. High installation and operational costs associated with PET systems remain a significant barrier, particularly in developing economies. Additionally, the short half-life of commonly used radiotracers, including fluorine-18, limits transportation and storage capabilities, impacting operational efficiency.
Reimbursement reductions in certain healthcare systems may also hinder market growth over the forecast period.
Key Industry Developments
Recent developments highlight the ongoing innovation within the PET imaging sector:
- In March 2021, Cerveau Technologies Inc. partnered with Alector LLC to commercialize investigational imaging agent MK-6240 for PET scans targeting neurofibrillary tangles in the brain.
- In February 2021, Siemens Healthineers introduced its advanced Biograph Vision PET/CT system at the Hospital of the University of Pennsylvania, marking the first installation of the technology in the United States.
Key Players Operating in the Market
Major companies operating in the global PET scanners market include:
GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems Corporation
Shimadzu Corporation
United Imaging Healthcare
Neusoft Medical Systems
Bruker Corporation
Carestream Health
The increasing focus on precision diagnostics, growing adoption of hybrid imaging technologies, and rising demand for early disease detection are expected to continue driving growth in the global positron emission tomography scanners market over the coming years.
You Might Like Also
